UC Davis Health Stadium

BioIntelliSense and UC Davis Health Launch Continuous Monitoring Program for Bone Marrow Transplant Patients

Retrieved on: 
Thursday, November 16, 2023
Wearables, Mobile Technology, Biometrics, Other Health, Artificial Intelligence, Oncology, Software, Medical Devices, Hardware, Hospitals, Professional Services, Technology, General Health, Biotechnology, Data Analytics, Surgery, Health, University, Health Technology, Education, Risk, Respiratory rate, Patient, Sleep medicine, Rest, FDA, CIO, Digital, MD, Skin temperature, University of California, Davis, News, Vital signs, Critical care, UC, UC Davis Health Stadium, Medical imaging, Nursing, Pharmaceutical industry

BioIntelliSense , a continuous health monitoring and clinical intelligence company, and California-based UC Davis Health announce the launch of a new in-hospital monitoring initiative for patients hospitalized for Bone Marrow Transplant and Hematology/Oncology services.

Key Points: 
  • BioIntelliSense , a continuous health monitoring and clinical intelligence company, and California-based UC Davis Health announce the launch of a new in-hospital monitoring initiative for patients hospitalized for Bone Marrow Transplant and Hematology/Oncology services.
  • “Smart care is the future of healthcare, and we are delivering on that promise with the introduction of this continuous care program at UC Davis Health.”
    An award-winning academic medical center, UC Davis Health is a recognized leader in advancing digital transformation initiatives focused on equitable, accessible, and cost-effective patient care.
  • The BioIntelliSense project has been led and driven by the cutting-edge UC Davis Health Digital CoLab and their commitment to identifying, evaluating, and implementing best-in-class technologies and programs.
  • “We want to empower our clinical teams with the most advanced tools available, so they can effectively and efficiently personalize every patient’s care.

Wooster Community Hospital's Eric Gasser Earns the 2023 Stoltenberg Future Fund Health IT Leadership Scholarship

Retrieved on: 
Tuesday, November 14, 2023
CHIME, EHR, Information, HIT, Gasser, Consultant, Workforce, Hospital, Informatics, Patient, College, Dayton Children's Hospital, Brooke Army Medical Center, CIO, CPOE, Texas Children's Hospital, Documentation, Magic, Conference, MEDITECH, MBA, UNC Health Care, University, Jackson Health System, Health care, Education, Family, UC, Computerized physician order entry, Health, UC Davis Health Stadium, Nursing, Management

PITTSBURGH, Nov. 14, 2023 /PRNewswire-PRWeb/ -- Stoltenberg Consulting, Inc., a leading healthcare IT consulting firm, today named Eric Gasser, vice president and chief information officer (CIO) at Wooster Community Hospital in Wooster, Ohio, as the recipient of the 2023 Stoltenberg Future Fund Scholarship for healthcare technology leadership continuing education.

Key Points: 
  • Stoltenberg Consulting's CHIME Education Foundation scholarship helps advance health tech leaders, with Wooster Community Hospital CIO named as the 2023 recipient.
  • PITTSBURGH, Nov. 14, 2023 /PRNewswire-PRWeb/ -- Stoltenberg Consulting, Inc. , a leading healthcare IT consulting firm, today named Eric Gasser, vice president and chief information officer (CIO) at Wooster Community Hospital in Wooster, Ohio, as the recipient of the 2023 Stoltenberg Future Fund Scholarship for healthcare technology leadership continuing education.
  • By supporting health IT leadership development, the scholarship promotes digital health advancement and technology-enabled patient engagement in hospitals and health systems.
  • Gasser plans to utilize the Stoltenberg Future Fund Scholarship toward his MBA education at the University of Akron this fall.

NRC Health unveils winners of 2023 patient experience and loyalty awards

Retrieved on: 
Tuesday, August 8, 2023
New England Aquarium, New England, Success, Marital status, Mayo Clinic Hospital (Rochester), University, Beth Israel Deaconess Medical Center, National Research Corporation, Patient experience, NRC, Hospital, Health, Human, Sea, Organization, NPS, Hospital of the University of Pennsylvania, Missouri Baptist Medical Center, Community hospital, Monterey Peninsula, UC, The Christ Hospital, UC Davis Health Stadium, Patient, Lahey Hospital & Medical Center, California Hospital Medical Center, Christ Hospital, Parkview Health, Pharmaceutical industry, Nursing, Mercy, Troy

LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.

Key Points: 
  • LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.
  • NRC Health's Consumer Loyalty Award winners lead the way in delivering exceptional patient experiences.
  • Elevating the patient experience remains a priority in healthcare, and NRC Health's 2023 Excellence in Patient Experience Award winners have demonstrated outstanding commitment to individualized and human-centered care.
  • To check whether your local hospital is a 2023 honoree, see the full lists of winning organizations for both the 2023 Consumer Loyalty Awards and the 2023 Excellence in Patient Experience Awards .

NRC Health unveils winners of 2023 patient experience and loyalty awards

Retrieved on: 
Tuesday, August 8, 2023
New England Aquarium, New England, Success, Marital status, Mayo Clinic Hospital (Rochester), University, Beth Israel Deaconess Medical Center, National Research Corporation, Patient experience, NRC, Hospital, Health, Human, Sea, Organization, NPS, Hospital of the University of Pennsylvania, Missouri Baptist Medical Center, Community hospital, Monterey Peninsula, UC, The Christ Hospital, UC Davis Health Stadium, Patient, Lahey Hospital & Medical Center, California Hospital Medical Center, Christ Hospital, Parkview Health, Pharmaceutical industry, Nursing, Mercy, Troy

LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.

Key Points: 
  • LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.
  • NRC Health's Consumer Loyalty Award winners lead the way in delivering exceptional patient experiences.
  • Elevating the patient experience remains a priority in healthcare, and NRC Health's 2023 Excellence in Patient Experience Award winners have demonstrated outstanding commitment to individualized and human-centered care.
  • To check whether your local hospital is a 2023 honoree, see the full lists of winning organizations for both the 2023 Consumer Loyalty Awards and the 2023 Excellence in Patient Experience Awards .

SmithGroup Selects Roxanne Malek as New Managing Partner

Retrieved on: 
Wednesday, June 7, 2023
Science, DNA, K.L.E Society's KLE College of Engineering and Technology, Society, PE, LEED AP, University of California, Berkeley, University, Education, Stanford University, LEED, SmithGroup, Contra Costa Community College District, University of California, San Francisco, California State University, Chico, AP, Partner (business rank), Contra Costa, Higher education, DBIA, American City Business Journals, NCARB, Society for College and University Planning, American Institute of Architects, UC, UC Davis Health Stadium, Risk, Engineering, Growth, Woman, House of Medici, American Institute, AIA, Sykes, Management, Industrial design

Roxanne Malek , AIA, LEED AP BD+C, DBIA has been named as a Managing Partner, joining Russ Sykes , PE, LEED AP and Troy Thompson , AIA, LEED AP to form the three-person team leading the firm.

Key Points: 
  • Roxanne Malek , AIA, LEED AP BD+C, DBIA has been named as a Managing Partner, joining Russ Sykes , PE, LEED AP and Troy Thompson , AIA, LEED AP to form the three-person team leading the firm.
  • Malek succeeds Mike Medici, AIA, NCARB who has served as a Managing Partner with Sykes and Thompson since 2015.
  • Medici, a 42-year veteran of SmithGroup, will support a number of initiatives for the firm through November.
  • Malek has been with SmithGroup for over 25 years, first joining the Science and Technology studio in its San Francisco office.

Orgenesis and University of California, Davis Sign Partnership Agreement for Rollout of Cell and Gene Therapy Mobile Processing Units and Labs Throughout California

Retrieved on: 
Wednesday, June 7, 2023
University of California, Davis, Partnership, University, CGT, Therapy, Gene, California Institute for Regenerative Medicine, Regents of the University of California, Regenerative medicine, Delaware General Corporation Law, Hospital, UC, UC Davis Health Stadium, Patient, CIRM, POC, Pharmaceutical industry

and DAVIS, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) at the point of care, and University of California, Davis (UC Davis) , today announce an agreement to roll out proprietary Orgenesis Mobile Processing Units and Labs™ (“OMPULs™”) at medical or academic institutions within the University of California system.

Key Points: 
  • and DAVIS, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) at the point of care, and University of California, Davis (UC Davis) , today announce an agreement to roll out proprietary Orgenesis Mobile Processing Units and Labs™ (“OMPULs™”) at medical or academic institutions within the University of California system.
  • These units will enable point-of-care treatment via the development and manufacture of cell and gene therapies from Orgenesis, its partners, and UC Davis’ partners, subject to further agreements.
  • Since joining the Orgenesis POCare Network in 2020 , UC Davis Health has been utilizing Orgenesis’ POCare Service Platform to develop and supply cell and gene products and therapies.
  • The first collaboration involved scaling up and integrating UC Davis’ lentiviral vector process for localized development and processing of cell and gene therapies for treating patients.

Verizon Business returns with 5G Innovation Session Tour, kicking-off in Chicago

Retrieved on: 
Wednesday, April 12, 2023
LeTourneau Empowering Global Solutions, Travel, Senior, Life, Ericsson, RSVP, Internet, Robotics, STEM, Government, ESG, SVP, High-pass filter, Product marketing, Business development, Smartphone, Growth, Social media, Acceleration, Business, Luigi, UC, Internet access, IBM, Soldier Field, Verizon Business, Education, Private, School, Student, UC Davis Health Stadium, City, XR, Management, Cable television, Tutoring, Innovation, Verizon Communications, Sales management

Partnering with Ericsson for this first event, Verizon Business is kicking off the 2023 tour, planned for six cities, with a session at Chicago’s legendary Soldier Field.

Key Points: 
  • Partnering with Ericsson for this first event, Verizon Business is kicking off the 2023 tour, planned for six cities, with a session at Chicago’s legendary Soldier Field.
  • The first session will feature presentations, panels, and demonstrations by industry leaders and product experts from Verizon Business, Ericsson, Medivis, UC Davis Health, IBM and KSI Data Sciences.
  • “The magic of 5G and edge computing comes to life when we put our heads together with partners and co-innovate,” said Jennifer Artley, SVP, 5G Acceleration, Verizon Business.
  • “We’re seeing strong momentum for 5G private networks,” said Sandra Cutrona, Vice President and Head of Business Development for Customer Unit Verizon, Ericsson North America.

Orgenesis Signs MOU with University of California, Davis to Develop a Collaboration Agreement to Deploy Cell and Gene Therapy Mobile Processing Units and Labs Across California

Retrieved on: 
Thursday, March 16, 2023
POC, University of California, Davis, Fausto Pocar, Hospital, MOU, Partnership, CGT, Regents of the University of California, Patient, University, UC Davis Health Stadium, Point of care, UC, Pharmaceutical industry

Both Orgenesis, through Orgenesis POC CA, and the University, aim to roll out the OMPULs within the State of California in a staged approach.

Key Points: 
  • Both Orgenesis, through Orgenesis POC CA, and the University, aim to roll out the OMPULs within the State of California in a staged approach.
  • The intent is to enable the development and manufacture of cell and gene therapies from Orgenesis, its partners, and UC Davis’ partners.
  • “The cell and gene therapy sector continues to expand and develop solutions for patients suffering from a range of conditions.
  • UC Davis Health has been utilizing Orgenesis’ POCare platform to develop, commercialize and supply cell and gene products and therapies.

Estrella Biopharma Announces FDA Clearance of IND Application for Phase I/II Clinical Trial (Starlight-1) of EB103, a CD19-Targeted ARTEMIS® T Cell Therapy, to Patients with B-Cell Lymphomas

Retrieved on: 
Wednesday, March 8, 2023
UTPD, IND, Acquisition, CRS, Cytokine release syndrome, NHL, Investigational New Drug, UC Davis Health Stadium, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Neurotoxicity, Patient, Cancer, HIV, Food, Immune system, Lymphoma, CNS, FDA, CD19, B-cell leukemia, Safety, UC, Pharmaceutical industry

EMERYVILLE, Calif. and NEW YORK, March 8, 2023 /PRNewswire/ -- Estrella Biopharma, Inc. ("Estrella"), a biopharmaceutical company whose mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer with safe, effective therapies, and TradeUP Acquisition Corp. ("TradeUP") (NASDAQ: UTPD), a special purpose acquisition company formed for the purpose of effecting a merger, acquisition or similar business combination, today announced that the U.S. Food and Drug Administration ("FDA") has cleared Estrella's Investigational New Drug ("IND") application for Estrella's lead product candidate, EB103, a T-cell therapy targeting CD19, a protein expressed on the surface of almost all B-cell leukemias and lymphomas, paving the way for Estrella to initiate a Phase I/II clinical trial of EB103 to treat relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) patients, including clearance to treat patients with some of the highest unmet medical needs, including those with human immunodeficiency virus (HIV)-associated lymphoma, and primary and secondary central nervous system (CNS) lymphoma.

Key Points: 
  • "Our goal is to develop a safe and effective therapy that can help address the unmet medical needs of patients with R/R B-cell malignancies, including those who are currently underserved by existing therapies.
  • We hope to enroll our first patient in the second half of 2023."
  • The Starlight-1 Phase I/II clinical trial is designed to assess the safety, tolerability, recommended Phase II dose (RP2D), and preliminary anti-cancer activity of EB103 for the treatment of R/R B-cell NHL patients.
  • The study is expected to enroll patients initially at UC Davis Health.

Press Ganey Honors HX23 Award Winners for Remarkable Leadership in Advancing the Human Experience of Healthcare

Retrieved on: 
Wednesday, February 8, 2023
Nursing, Health, Health Technology, Other Health, Managed Care, General Health, MBA, CCRN, Medical director, Walt Disney, Health equity, Patient safety, Physician, Morale, RN, FAHA, Light, Corporation, American Heart Association, Arnot Ogden Medical Center, Patient, FACC, Culture, Research, New York City Department of Health and Mental Hygiene, UC Davis Health Stadium, Beauty, NYC Health + Hospitals, UC, COVID, University of California, Davis, COVID-19, Press Ganey Associates, FASA, NEXT Woman of the Year awards, Doctor of Philosophy, Association of Black Cardiologists, Management, MD

Press Ganey , the renowned leader in patient, member, employee and consumer experience across the healthcare ecosystem, today announced the recipients of its HX23 Awards, at the organization’s annual national client conference.

Key Points: 
  • Press Ganey , the renowned leader in patient, member, employee and consumer experience across the healthcare ecosystem, today announced the recipients of its HX23 Awards, at the organization’s annual national client conference.
  • Recipients of these prestigious achievement awards were honored on stage by Press Ganey executive leaders during the event, which took place in Orlando, Florida this week.
  • These honorees exemplify the excellence, resilience, and spirit needed to enhance and enrich the human experience of healthcare,” said Patrick T. Ryan, Executive Chairman, Press Ganey.
  • This year’s recipient, Dr. Robert Phillips, is a dedicated and qualified leader and mentor and a living example of what it means to practice human experience healthcare.